Logo image of GXI.DE

GERRESHEIMER AG (GXI.DE) Stock Price, Quote, News and Overview

FRA:GXI - Deutsche Boerse Ag - DE000A0LD6E6 - Common Stock - Currency: EUR

80.15  +0.05 (+0.06%)

GXI.DE Quote, Performance and Key Statistics

GERRESHEIMER AG

FRA:GXI (3/7/2025, 7:00:00 PM)

80.15

+0.05 (+0.06%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High110.1
52 Week Low62.9
Market Cap2.77B
Shares34.54M
Float32.59M
Yearly Dividend1.32
Dividend Yield1.56%
PE25.2
Fwd PE14.48
Earnings (Next)04-08 2025-04-08
IPO06-11 2007-06-11


GXI.DE short term performance overview.The bars show the price performance of GXI.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15 -20

GXI.DE long term performance overview.The bars show the price performance of GXI.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20 -20

The current stock price of GXI.DE is 80.15 EUR. In the past month the price increased by 1.2%. In the past year, price decreased by -23.52%.

GERRESHEIMER AG / GXI Daily stock chart

GXI.DE Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TN8.DE THERMO FISHER SCIENTIFIC INC 24.07 182.78B
DAP.DE DANAHER CORP 28.32 139.67B
DIM.PA SARTORIUS STEDIM BIOTECH 55.77 19.00B
56S1.DE SARTORIUS STEDIM BIOTECH 55.17 18.79B
SRT3.DE SARTORIUS AG-VORZUG 46.36 17.15B
SRT.DE SARTORIUS AG 37.17 13.75B
ILU.DE ILLUMINA INC 34.19 12.24B
ESF0.DE EUROFINS SCIENTIFIC 28.63 9.95B
ERF.PA EUROFINS SCIENTIFIC 28.53 9.91B
QIA.DE QIAGEN N.V. 18.07 7.89B
1SXP.DE SCHOTT PHARMA AG& CO KGAA 25.09 3.74B
EVT.DE EVOTEC SE N/A 2.34B

About GXI.DE

Company Profile

GXI logo image Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 12,012 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.

Company Info

GERRESHEIMER AG

Klaus-Bungert-Strasse 4

Dusseldorf NORDRHEIN-WESTFALEN DE

Employees: 11913

Company Website: https://www.gerresheimer.com/

Investor Relations: http://www.gerresheimer.com/en/company/investor-relations/reports

Phone: 49211618100

GERRESHEIMER AG / GXI.DE FAQ

What is the stock price of GERRESHEIMER AG today?

The current stock price of GXI.DE is 80.15 EUR. The price increased by 0.06% in the last trading session.


What is the ticker symbol for GERRESHEIMER AG stock?

The exchange symbol of GERRESHEIMER AG is GXI and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is GXI.DE stock listed?

GXI.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for GERRESHEIMER AG stock?

24 analysts have analysed GXI.DE and the average price target is 103.85 EUR. This implies a price increase of 29.57% is expected in the next year compared to the current price of 80.15. Check the GERRESHEIMER AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GERRESHEIMER AG worth?

GERRESHEIMER AG (GXI.DE) has a market capitalization of 2.77B EUR. This makes GXI.DE a Mid Cap stock.


How many employees does GERRESHEIMER AG have?

GERRESHEIMER AG (GXI.DE) currently has 11913 employees.


What are the support and resistance levels for GERRESHEIMER AG (GXI.DE) stock?

GERRESHEIMER AG (GXI.DE) has a support level at 80.14 and a resistance level at 80.25. Check the full technical report for a detailed analysis of GXI.DE support and resistance levels.


Is GERRESHEIMER AG (GXI.DE) expected to grow?

The Revenue of GERRESHEIMER AG (GXI.DE) is expected to grow by 21.07% in the next year. Check the estimates tab for more information on the GXI.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy GERRESHEIMER AG (GXI.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GERRESHEIMER AG (GXI.DE) stock pay dividends?

GERRESHEIMER AG (GXI.DE) has a dividend yield of 1.56%. The yearly dividend amount is currently 1.32. Check the full fundamental report for a detailed analysis of GXI.DE dividend history, reliability and sustainability.


When does GERRESHEIMER AG (GXI.DE) report earnings?

GERRESHEIMER AG (GXI.DE) will report earnings on 2025-04-08.


What is the Price/Earnings (PE) ratio of GERRESHEIMER AG (GXI.DE)?

The PE ratio for GERRESHEIMER AG (GXI.DE) is 25.2. This is based on the reported non-GAAP earnings per share of 3.18 and the current share price of 80.15 EUR. Check the full fundamental report for a full analysis of the valuation metrics for GXI.DE.


GXI.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to GXI.DE. When comparing the yearly performance of all stocks, GXI.DE is a bad performer in the overall market: 85.67% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

GXI.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to GXI.DE. GXI.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GXI.DE Financial Highlights

Over the last trailing twelve months GXI.DE reported a non-GAAP Earnings per Share(EPS) of 3.18. The EPS decreased by -7.9% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.39%
ROA 2.88%
ROE 7.26%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%-11%
Sales Q2Q%4.35%
EPS 1Y (TTM)-7.9%
Revenue 1Y (TTM)2.28%

GXI.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to GXI.DE. The Buy consensus is the average rating of analysts ratings from 24 analysts.

For the next year, analysts expect an EPS growth of 20.03% and a revenue growth 21.07% for GXI.DE


Ownership
Inst Owners96.73%
Ins Owners4.92%
Short Float %N/A
Short RatioN/A
Analysts
Analysts84.17
Price Target103.85 (29.57%)
EPS Next Y20.03%
Revenue Next Year21.07%